The company
Coherus Oncology, Inc.
CHRS · Nasdaq
CHRS stood above a rising 150-day average in 28 of the last 52 weekly readings, and has been out of that trend for the last 23 weeks. It is 34.8% below that average now. Biotechnology: 16% of its 561 stocks in an uptrend (−15 points in four weeks); Health Care: 26% (−10 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 23
- Industry in uptrend
- 16% -15 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $0
- Officials’ trades on record
- 1
- Institutions holding
- 142 (-5)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 28 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
1 disclosed lines: House 1, Senate 0, executive 0; 1 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Shri Thanedar House: U.S. House ClerkMI13 | sold | $15k–$50k | 23 Jan 2023filed 9 Feb 2023 |
Insiders
No open-market buy or sale by its insiders on record.
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| Timothy G. Youngquist 2020 Irrevocable Trustadded · filed 7 Aug 2026 | 13,050,623$18.3M | +759,823+6.2% |
| BlackRock, Inc.added · filed 7 Aug 2026 | 12,003,316$16.8M | +1,638,242+15.8% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 5,949,490$8.3M | +496,728+9.1% |
| GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026 | 3,685,567$5.2M | +563,989+18.1% |
| SAMSARA BIOCAPITAL, LLCunchanged · filed 14 Aug 2026 | 3,428,571$4.8M | 00.0% |
| Kohlberg Kravis Roberts & Co. L.P.unchanged · filed 14 Aug 2026 | 3,036,076$4.2M | 00.0% |
| STATE STREET CORPadded · filed 7 Aug 2026 | 2,382,305$3.3M | +56,446+2.4% |
| TWO SIGMA INVESTMENTS, LPreduced · filed 14 Aug 2026 | 2,259,412$3.2M | -42,589−1.9% |
| CM Management, LLCunchanged · filed 13 Aug 2026 | 2,100,000$2.9M | 00.0% |
| Alyeska Investment Group, L.P.reduced · filed 14 Aug 2026 | 1,733,234$2.4M | -516,766−23.0% |
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.